Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Dopamine Receptor D1 Blocking Peptide (AC1207)
Cat.#: ACPP-1207
Specifications
Despition Dopamine Receptor D1 Blocking Peptide for Immunodepletion, Immunocompetition SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1341 Pax2 Blocking Peptide (AC1341) 250 µg inquiry ACPP-1012 Recombinant Human Ninjurin 1 Protein (Fc Tag) (AC1012) 50 µg inquiry ACPP-1730 Human S100A8 Protein, His (AC1730) 2 µg inquiry ACPP-1009 Recombinant Human TYRO3 Protein (6×His Tag) (AC1009) 50 µg inquiry ACPP-1662 Human POFUT1 Protein (AC1662) 5 µg inquiry ACPP-1597 Human CRYGS Protein (AC1597) 5 µg inquiry ACPP-1757 Human Artemin Protein (AC1757) 5 µg inquiry ACPP-1369 Parkin Blocking Peptide (AC1369) 250 µg inquiry ACPP-1786 Human FGF 1 Protein (AC1786) 10 µg inquiry ACPP-1389 AHSG (AC1389) 10 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket